Sasol Ltd (SOL)
Johannesburg Exchange · South Africa · prices in ZAC · close of 22 Oct 2026
Key indicators
| Last close | ZAC 28,508.00 |
|---|---|
| 52-week range | 9,325.00 – 28,750.00 |
| Return, 1 month / 3 months | +29.0% / +53.1% |
| Return, 1 year / 3 years | +195.0% / +14.6% |
| Trend | Uptrend |
| RSI (14) | 78 |
| Volatility (1 year) | 62.6% |
| Worst drawdown (1 year) | -34.7% |
| Average daily value traded | 68,600.26M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sasol is a South African energy and chemicals company based in Johannesburg that converts coal and natural gas into liquid fuels and a broad range of chemical products. Its operations include mining coal, producing synthetic fuels and pipeline gas, and manufacturing chemicals such as solvents, polymers, waxes and fertilisers. It supplies fuel and chemical customers in South Africa and exports chemicals to markets around the world.
Sasol Ltd trades under the code SOL on the Johannesburg Exchange in South Africa, with its price quoted in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sasol Ltd (SOL) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 28,508.00 on 22 October 2026.
Its price-based Market X-Ray is 78 out of 100 (a strong price profile), ranking 10 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 195.0% and over the last three months it rose 53.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 99 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 51.0% | ||
| From 52-week high | 0.0% | ||
| Momentum | 98 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 53.1% | ||
| 6-month return | 31.0% | ||
| 12-month return, skipping the last month | 128.7% | ||
| Stability (higher is calmer) | 28 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 62.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.7% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 68,600.26M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +7.1% |
|---|---|
| 1 month | +29.0% |
| 3 months | +53.1% |
| 6 months | +31.0% |
| 1 year | +195.0% |
| 3 years | +14.6% |
| 5 years | +23.2% |
Signals
| 50-day / 200-day average | 22,400.08 / 18,883.06 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1,119.87 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Mar 2024 | ZAC 200.0000 |
| 13 Sep 2023 | ZAC 1,000.0000 |
| 8 Mar 2023 | ZAC 700.0000 |
| 7 Sep 2022 | ZAC 1,470.0000 |
| 13 Mar 2019 | ZAC 590.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.